Resmed Inc. buy KeyCorp
Start price
31.01.25
/
50%
€232.00
Target price
31.01.26
€269.28
Performance (%)
-7.63%
End price
01.02.26
€214.30
Summary
This prediction ended on 01.02.26 with a price of €214.30. With a performance of -7.63%, the BUY prediction for Resmed Inc. by KeyCorp closed slightly in the red. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €0.51 was paid as dividends for this prediction. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 3.338% | 3.338% | -0.857% |
| iShares Core DAX® | 1.432% | 2.628% | 12.457% |
| iShares Nasdaq 100 | 1.892% | -0.458% | 1.248% |
| iShares Nikkei 225® | -1.619% | 11.097% | 27.382% |
| iShares S&P 500 | 1.921% | 1.159% | 1.635% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $266.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten